LD-2 disclosure · 1st Quarter - Report
SPERO OPCO, INC.
Income$10Kfee reported
Client
- Name
- SPERO OPCO, INC.
- Description
- Spero Therapeutics develops novel therapies to treat highly resistant bacterial infections
- Location
- Massachusetts · United States of America
Registrant
- Description
- Consulting
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueHealth Issues
Development of policies to advance the antimicrobial research and development environment. Support HR 512 - DISARM Act of 2015
LobbyistsJOHN MCMANUS · LINDSAY BEALOR · BARRETT THORNHILL · CHASE M THOMAS
TargetedSENATE · HOUSE OF REPRESENTATIVES